High-dose rate brachytherapy has a curative potential in patients with intraluminal squamous cell lung cancer.
Two patients presented with intraluminal T1N0 squamous cell lung cancer. Poor lung function precluded surgical resection and/or external radiotherapy. They were treated up to 3 times with high-dose rate brachytherapy (10 Gy at 1 cm each session) with curative intent. Follow-up has been 54 and 25 months. Brachytherapy is an effective and well-tolerated bronchoscopic treatment alternative with a curative potential in patients with small T1N0 intraluminal lung cancer.
Sutedja
G
G
Department of Pulmonary Medicine, Free University Hospital, Amsterdam, The Netherlands.
Baris
G
G
van Zandwijk
N
N
Postmus
P E
PE
D000368:Aged; D001918:Brachytherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage